Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial

Urbonas V., Schadendorf D., Zimmer L., Danson S., Marshall E., Corrie P., Wheater M., Plummer E., Mauch C., Scudder C., Goff M., Love SB., Mohammed SB., Middleton MR.

DOI

10.1093/annonc/mdy500

Type

Journal article

Journal

Annals of Oncology

Publisher

Oxford University Press (OUP)

Publication Date

01/02/2019

Volume

30

Pages

317 - 324

Permalink Original publication